Jump to Navigation

Publicaties 2005

Publicaties 2005:

  • Arens R, Baars PA, Jak M, Tesselaar K, van der Valk M, van Oers MHJ, van Lier RAW. Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation. J IMMUNOL 2005;174(10):5915-5920.     [ PubMed ]

 

  • Beiboer SHW, Wieringa-Jelsma T, Maaskant-van Wijk PA, van der Schoot CE, van Zwieten R, Roos D, den Dunnen JT, de Haas M. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. TRANSFUSION 2005;45(5):667-679.     [ PubMed ]

 

  • Bianchi DW, Avent ND, Costa JM, van der Schoot CE. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. OBSTET GYNECOL 2005;106(4):841-844.     [ PubMed ]

 

  • Bilgin YM, van de Watering LMG, Eijsman L, Versteegh MIM, van Oers MHJ, Brand A. Bloedtransfusies en postoperatieve complicaties na hartklepchirurgie. HART BULL 2005;36(4):108-112.  

 

  • Borghans JAM, Hazenberg MD, Miedema F. Limited role for the thymus in SIV pathogenesis. EUR J IMMUNOL 2005;35(1):42-45.     [ PubMed ]

 

  • Breems DA, Boogaerts MA, Dekker AW, van Putten WLJ, Sonneveld P, Huijgens PC, van der Lelie J, Vellenga E, Gratwohl A, Verhoef GEG, Verdonck LF, Löwenberg B. Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial. BRIT J HAEMATOL 2005;128(1):59-65.  

 

  • Breems DA, van Putten WLJ, Huijgens PC, Ossenkoppele GJ, Verhoef GEG, Verdonck LF, Vellenga E, de Greef G, Jacky E, van der Lelie J, Boogaerts MA, Lowenberg B. Prognostic index for adult patients with acute myeloid leukemia in first relapse. J CLIN ONCOL 2005;23(9):1969-1978.  

 

  • Daniels G, van der Schoot CE, Olsson ML. Report of the First International Workshop on molecular blood group genotyping. VOX SANG 2005;88(2):136-142.     [ PubMed ]

 

  • Deloose STP, Smit LA, Pals FT, Kersten MJ, van Noesel CJM, Pals ST. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. LEUKEMIA 2005;19(5):851-855.     [ PubMed ]

 

  • Dicker F, Kater AP , Fukuda T, Kipps TJ. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells. BLOOD 2005;105(8):3193-3198.  

 

  • Dijkstra-Tiekstra MJ, van der Schoot CE, Pietersz RNI, Reesink HW. White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods. VOX SANG 2005;88(4):275-277.     [ PubMed ]

 

  • Dohmen SE, Mulder A, Verhagen OJHM, Eijsink C, Franke-van Dijk MEI, van der Schoot CE. Production of recombinant Ig molecules from antigen-selected single B cells and restricted usage of Ig-gene segments by anti-D antibodies. J IMMUNOL METHODS 2005;298(1-2):9-20.     [ PubMed ]

 

  • Gallegos Ruiz MI, van Oers MHJ, Kersten MJ. Rituximab: de 'magic bullet' in de bestrijding van het B-cel-non-Hodgkin-lymfoom? Werkingsmechanismen en mogelijke oorzaken van resistentie. NED TIJDSCHR HEMATOL 2005;2(5):184-191.  

 

  • Glas AM, Kersten MJ , Delahaye LJMJ, Witteveen AT, Kibbelaar RE, Velds A, Wessels LFA, Joosten P, Kerkhoven RM, Bernards R, van Krieken JHJM, Kluin PM, van't Veer LJ, de Jong D. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. BLOOD 2005;105(1):301-307.  

 

  • Grootkerk-Tax MGHM, Maaskant-van Wijk PA, van Drunen J, van der Schoot CE. The highly variable RH locus in nonwhite persons hampers RHD zygosity determination but yields more insight into RH-related evolutionary events. TRANSFUSION 2005;45(3):327-337.     [ PubMed ]

 

  • Hagenbeek A. Future trends in radioimmunotherapy. SEMIN ONCOL 2005;32(1 Suppl 1):S57-S62.     [ PubMed ]

 

  • Hagenbeek A, Lewington V. Report of a European consensus workshop to develop recommendations for the optimal use of (90)Y-ibritumomab tiuxetan (Zevalin) in lymphoma. ANN ONCOL 2005;16(5):786-792.     [ PubMed ]

 

  • Harris JM, Hazenberg MD, Poulin JF, Higuera-Alhino D, Schmidt D, Gotway M, McCune JM. Multiparameter evaluation of human thymic function: interpretations and caveats. CLIN IMMUNOL 2005;115(2):138-146.     [ PubMed ]

 

 

  • Hunting CB, Deloose STP, de Valk B, Kersten MJ. Ziekte van Castleman. NED TIJDSCHR HEMATOL 2005;2(1):22-27.  

 

  • Ivanov R. Minor histocompatibility antigens as targets for immunogenetherapy of leukemia. Utrecht: s.n.; 2005. (-pp.) (PhD thesis. Supervisor(s):  Hagenbeek A; co-supervisor(s):  Ebeling SB)

 

  • Ivanov R, Aarts T, Hagenbeek A, Hol S, Ebeling S. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC. CYTOTHERAPY 2005;7(1):62-73.     [ PubMed ]

 

  • Ivanov R, Aarts T, Hol S, Doornenbal A, Hagenbeek A, Petersen E, Ebeling S. Identification of a 40S ribosomal protein S4-derived H-Y epitope able to elicit a lymphoblast-specific cytotoxic T lymphocyte response. CLIN CANCER RES 2005;11(5):1694-1703.     [ PubMed ]

 

  • Ivanov R, Hol S, Aarts T, Hagenbeek A, Slager EH, Ebeling S. UTY-specific TCR-transfer generates potential graft-versus-leukaemia effector T cells. BRIT J HAEMATOL 2005;129(3):392-402.     [ PubMed ]

 

  • Juffermans NP, Jager A, Kersten MJ , van Oers MH, Hommes DW. Epstein-Barr-virus-gerelateerde lymfomen bij patiënten met inflammatoire darmziekte. NED TIJDSCHR GENEESKD 2005;149(33):1859-1863.     [ PubMed ]

 

  • Kater AP , Dicker F, Mangiola M, Welsh K, Houghten R, Ostresh J, Nefzi A, Reed JC, Pinilla C, Kipps TJ. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis. BLOOD 2005;106(5):1742-1748.  

 

  • Kater AP , van Oers MHJ. Chronic lymphocytic leukemia: time for a risk-adapted approach.  In: Romero RM, editors. Trends in leukemia research. S.l.: Nova Science Publishers, Inc; 2005. p. 363-383.

 

  • Kersten MJ. Monoklonale antilichaamtherapie bij B-cel chronische lymfatische leukemie.  In: Immuuntherapie van hematologische ziekten. ?: ?; 2005. p. 41-46.

 

  • Kersten MJ. Rituximab immunotherapy in the treatment of B-cell non-Hodgkin's lymphoma. EUR J HOSP PHARM 2005;II(4):18-19.  

 

  • Koning FA, Otto SA, Hazenberg MD, Dekker L, Prins M, Miedema F, Schuitemaker H. Low-level CD4(+) T cell activation is associated with low susceptibility to HIV-1 infection. J IMMUNOL 2005;175(9):6117-6122.     [ PubMed ]

 

  • Mackus WJM, Kater AP , Grummels A, Evers LM, Hooijbrink B, Kramer MHH, Castro JE, Kipps TJ, van Lier RAW, van Oers MHJ, Eldering E. Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation. LEUKEMIA 2005;19(3):427-434.     [ PubMed ]

 

  • Mank A, Winters N. Eerder met ontslag?. ONCOLOGICA 2005;22:14-18.

 

  • Nolte MA, Arens R, van Os R, van Oosterwijk M, Hooibrink B, van Lier RAW, van Oers MHJ. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. NAT IMMUNOL 2005;6(4):412-418.     [ PubMed ]

 

  • Piriou E. Viro-immunoloy of EBV - HIV co-infection. S.l.: s.n.; 2005. (136pp.) (ISBN 90-9019155-0) (PhD thesis. Supervisor(s):  Miedema F, van Oers MHJ; co-supervisor(s):  van Baarle D) [ UvA Dissertations Online ]

 

  • Piriou E, Jansen CA, van Dort K, de Cuyper I, Nanlohy NM, Lange JMA, van Oers MHJ, Miedema F, van Baarle D. Reconstitution of EBV latent but not lytic antigen-specific CD4(+) and CD8(+) T cells after HIV treatment with highly active antiretroviral therapy. J IMMUNOL 2005;175(3):2010-2017.     [ PubMed ]

 

  • Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects. EUR J IMMUNOL 2005;35(3):796-805.     [ PubMed ]

 

  • Piriou E, van Dort K, Nanlohy NM, van Oers MHJ, Miedema F, van Baarle D. Loss of EBNA1-specific memory CD4(+) and CD8(+) T cells in HIV-infected patients progressing to AIDS-related non-hodgkin lymphoma. BLOOD 2005;106(9):3166-3174.     [ PubMed ]

 

  • Qun X, Grootkerk-Tax MGHM, Maaskant-van Wijk PA, van der Schoot CE. Systemic analysis and zygosity determination of the RHD gene in a D-negative Chinese Han population reveals a novel D-negative RHD gene (vol 88, pg 35, 2005). VOX SANG 2005;89(4):271.  

 

  • Rohatiner AZS, Gregory WM, Peterson B, Borden E, Solal-Celigny P, Hagenbeek A, Fisher RI, Unterhalt M, Arranz R, Chisesi T, Aviles A, Lister TA. Meta-analysis to evaluate the role of interferon in follicular lymphoma. J CLIN ONCOL 2005;23(10):2215-2223.     [ PubMed ]

 

  • van Agthoven M, Kramer MHH, Sonneveld P, van der Hem KG, Huijgens PC, Wijermans PW, Kluin-Nelemans HC, Schaafsma MR, Biesma DH, Mattijssen V, Uyl-de Groot CA, Hagenbeek A. Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma. HAEMATOL-HEMATOL J 2005;90(10):1422-1432.     [ PubMed ]

 

  • van Beers EJ, Peters M, Biemond BJ. Pathofysiologie en behandeling van sikkelcelziekte. NED TIJDSCHR GENEESKD 2005;149(21):1144-1149.     [ PubMed ]

 

  • van den Berk G, Tonino S, de Fijter C, Smit W, Schultz MJ. Bench-to-bedside review: Preventive measures for contrast-induced nephropathy in critically ill patients. CRIT CARE 2005;9(4):361-370.     [ PubMed ]

 

  • van Hulst M, Bilgin YM, van de Watering LMG, de Vries R, van Oers MHJ, Brand A, Postma MJ. Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery. TRANSFUSION MED 2005;15(3):209-217.     [ PubMed ]

 

  • van Imhoff GW, van der Holt B, MacKenzie MA, Ossenkoppele GJ, Wijermans PW, Kramer MHH, van 't Veer MB, Schouten HC, van Marwijk Kooy M, van Oers MHJ, Raemaekers JMM, Sonneveld P, Meulendijks LAMH, Kluin PM, Kluin-Nelemans HC, Verdonck LF. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. LEUKEMIA 2005;19(6):945-952.     [ PubMed ]

 

  • van Oers MHJ. B-cel-chronische lymfatrische leukemie: risicostratificatie en behandeling. NED TIJDSCHR HEMATOL 2005;2(4):132-139.

 

  • van Royen N, Schirmer SH, Atasever B, Behrens CYH, Ubbink D, Buschmann EE, Voskuil M, Bot P, Hoefer I, Schlingemann RO, Biemond BJ, Tijssen JG, Bode C, Schaper W, Oskam J, Legemate DA, Piek JJ, Buschmann I. START trial - A pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. CIRCULATION 2005;112(7):1040-1046.     [ PubMed ]

 

  • Xu Q, Qun X, Grootkerk-Tax MGHM, Maaskant-van Wijk PA, van der Schoot CE. Systemic analysis and zygosity determination of the RHD gene in a D-negative Chinese Han population reveals a novel D-negative RHD gene. VOX SANG 2005;88(1):35-40.     [ PubMed ]

 

  • Zeerleder S, Hack CE, Caliezi C, van Mierlo G, Eerenberg-Belmer AJM, Wolbink A, Wuillenmin WA. Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction. CLIN IMMUNOL 2005;116(2):158-165.  
Auteur: B.M.J.M. Odijk, versie: 0.0, 13-01-2022